Seong-Yun Kim

Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro

H. Kuh, Jong-Kook Park, Jung-Won Lee, 2006, Anti-cancer drugs.

A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response

J. Seo, Jihyae Ann, Jeewoo Lee, 2022, Oncogene.

Pharmacodynamics of Antitumor Activity of Paclitaxel in Monolayers and Histocultures of Human NSCLC Cells

H. Kuh, Jong Kook Park, Seong-Yun Kim, 2005 .

β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features

J. Seo, Ji Young Kim, Soeun Park, 2022, Cancer Cell International.

Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase

Chaok Seok, Ji Young Kim, Soeun Park, 2023, Cellular and Molecular Life Sciences.

Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase

Chaok Seok, J. Seo, Ji Young Kim, 2023, Cellular and Molecular Life Sciences.

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR

Soeun Park, Lee Farrand, Seong-Yun Kim, 2023, Journal of Experimental & Clinical Cancer Research.

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer

Jihyae Ann, Jeewoo Lee, Soeun Park, 2024, Theranostics.